Company profile
DNAPrint Genomics, Inc.
OTC: DNAG · Healthcare · Biotechnology
PublicHQ Sarasota, Reports USD
#776 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
——FH —DQ —GM —SS 47
v0.1 · 5/100 weight · pillars only
↑ revenue growth (YoY), listing tenure · ↓ growth stability, market scale
Methodology →Revenue TTM
$1.9M
Rev growth YoY (TTM)
-15.2%
Net income (FY)
-$12.3M
Employees
24
as of 2026-08-29
Market cap
$12.9k
as of 2026-08-29
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$2.4M$2.4M2006
Net income-$12.3M-$12.3M2006
Operating income-$8.9M-$8.9M2006
Total assets$10.3M$10.3M2006
Liabilities$14.0M$14.0M2006
Equity-$3.7M-$3.7M2006
Revenue trend
FY2001 – FY2006 · USD
FY01
FY02
FY03
FY04
FY05
FY06
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is DNAPrint Genomics, Inc.’s revenue?
DNAPrint Genomics, Inc. booked $2.4M in FY2006 revenue, growing 91% year over year — faster than most Healthcare companies we track, at a -507.5% net margin.
Peers · Healthcare
Wayland Group Corp.——Lattice Biologics Ltd.——Quantum-Si incorporated40DPanacea Life Sciences Holdings, Inc.——Perimeter Medical Imaging AI, Inc.39DElicio Therapeutics, Inc.24DKey facts
CEOJatin Patel
SectorHealthcare
IndustryBiotechnology
HeadquartersSarasota, null
ExchangeOTC: DNAG
Employees24
IPO date2001-02-22
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.